%0 Generic
%T Abstract GS3-03: GS3-03 ARV-471, a PROTAC® estrogen receptor (ER) degrader in advanced ER-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study
%A Schott, Anne F.
%A Hurvitz, Sara
%A Ma, Cynthia
%A Hamilton, Erika
%A Nanda, Rita
%A Zahrah, George
%A Hunter, Natasha
%A Tan, Antoinette R.
%A Telli, Melinda
%A Mesias, Jesus Anampa
%A Jeselsohn, Rinath
%A Munster, Pamela
%A Lu, Haolan
%A Gedrich, Richard
%A Mather, Cecile
%A Parameswaran, Janaki
%A Han, Hyo S.
%I American Association for Cancer Research (AACR)
%@ 1538-7445
%D 2023
%C American Association for Cancer Research (AACR)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation